Skip to main content
Top
Published in: Journal of Nephrology 1/2019

01-02-2019 | Original Article

Novel markers of graft outcome in a cohort of kidney transplanted patients: a cohort observational study

Authors: C. Alfieri, A. Regalia, G. Moroni, D. Cresseri, F. Zanoni, M. Ikehata, P. Simonini, M. P. Rastaldi, G. Tripepi, C. Zoccali, C. Chatziantoniou, Piergiorgio Messa

Published in: Journal of Nephrology | Issue 1/2019

Login to get access

Abstract

Renal biopsy (RBx) informs about kidney transplantation (KTx) prognosis. In our observational study the prevalence of histological anomalies and the prognostic role of CD45, vimentin (VIM) and periostin (POSTN) in KTx-RBx have been evaluated. One hundred forty-six KTx-RBx (2009-2012) were analysed for general histology and in immunohistochemistry for CD45, VIM and POSTN. Clinical data of the 146-KTx patients were collected at the RBx time (T0), 6 and 12 months before and after RBx. Follow-up time was 21 ± 14 months. Glomerulosclerosis was 20% glomeruli/biopsy. Tubular atrophy (TA), Interstitial infiltrate (I-Inf) and interstitial fibrosis (IF) were slight in 21–18% and 25%, moderate in 22–30% and 26% and severe in 30–18% and 28% of patients. Fifty-eight percent of patients had lesions compatible with IF-TA. CD45, VIM and POSTN correlated to each-other and to TA, I-Inf and IF. VIM and POSTN correlated to GS. CD45 and VIM correlated directly to renal function (RF) and 25(OH)VitD, while POSTN inversely to 25(OH)VitD. Thirty patients restarted dialysis (HD+). HD+ had lower T0-eGFR, and higher CD45, VIM and POSTN than HD−. POSTN resulted the strongest in discriminate for HD+ . CD45, VIM and POSTN correlate to each-other and predict graft outcome. POSTN was the strongest in discriminate for HD+. 25(OH)VitD might influence inflammation and fibrosis in KTx.
Literature
1.
go back to reference Mengel M et al (2007) Infiltrates in protocol biopsies from renal allografts. Am J Transplant 7:356–365CrossRefPubMed Mengel M et al (2007) Infiltrates in protocol biopsies from renal allografts. Am J Transplant 7:356–365CrossRefPubMed
2.
go back to reference Zeisberg M, Kalluri R (2004) The role of epithelial-to-mesenchymal transition in renal fibrosis. J Mol Med 82:175–181CrossRefPubMed Zeisberg M, Kalluri R (2004) The role of epithelial-to-mesenchymal transition in renal fibrosis. J Mol Med 82:175–181CrossRefPubMed
3.
go back to reference Moreso F et al (2007) Immunephenotype of glomerular and interstitial infiltrating cells in protocol renal allograft biopsies and histological diagnosis. Am J Transplant 7:2739–2747CrossRefPubMed Moreso F et al (2007) Immunephenotype of glomerular and interstitial infiltrating cells in protocol renal allograft biopsies and histological diagnosis. Am J Transplant 7:2739–2747CrossRefPubMed
4.
go back to reference Hansson J et al (2014) Evidence for a morphologically distinct and functionally robust cell type in the proximal tubules of human kidney. Hum Pathol 45(2):382–393CrossRefPubMed Hansson J et al (2014) Evidence for a morphologically distinct and functionally robust cell type in the proximal tubules of human kidney. Hum Pathol 45(2):382–393CrossRefPubMed
5.
go back to reference Rastaldi MP et al (2002) Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies. Kidney Int 62:137–146CrossRefPubMed Rastaldi MP et al (2002) Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies. Kidney Int 62:137–146CrossRefPubMed
6.
go back to reference Doliana R, Bot S, Bonaldo P, Colombatti A (2000) EMI, a novel cysteine-rich domain of EMILINs and other extracellular proteins, interacts with the gC1q domains and participates in multimerization. FEBS Lett 484:164–168CrossRefPubMed Doliana R, Bot S, Bonaldo P, Colombatti A (2000) EMI, a novel cysteine-rich domain of EMILINs and other extracellular proteins, interacts with the gC1q domains and participates in multimerization. FEBS Lett 484:164–168CrossRefPubMed
7.
go back to reference Sorocos K et al (2011) Expression patterns and roles of periostin during kidney and ureter development. J Urol 186:1537–1544CrossRefPubMed Sorocos K et al (2011) Expression patterns and roles of periostin during kidney and ureter development. J Urol 186:1537–1544CrossRefPubMed
9.
go back to reference Levey AS et al (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461–470CrossRefPubMed Levey AS et al (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461–470CrossRefPubMed
10.
go back to reference Walker PD, Cavallo T, Bonsib SM (2004) Ad hoc committee on renal biopsy guidelines of the renal pathology society: Practice guidelines for the renal biopsy. Mod Pathol 17:1555–1563CrossRefPubMed Walker PD, Cavallo T, Bonsib SM (2004) Ad hoc committee on renal biopsy guidelines of the renal pathology society: Practice guidelines for the renal biopsy. Mod Pathol 17:1555–1563CrossRefPubMed
11.
go back to reference Sis B et al (2010) Banff ‘09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 10:464–471CrossRefPubMed Sis B et al (2010) Banff ‘09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 10:464–471CrossRefPubMed
12.
go back to reference Solez K et al (2007) Banff 05 meeting report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (CAN). Am J Transplant 7:518–526CrossRefPubMed Solez K et al (2007) Banff 05 meeting report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (CAN). Am J Transplant 7:518–526CrossRefPubMed
13.
go back to reference U S Renal Data System (2011) Annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda U S Renal Data System (2011) Annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda
14.
go back to reference Alarrayed S et al (2011) Why does kidney allograft fail? A long-term single-center experience. Saudi J Kidney Dis Transpl. 22:818–824PubMed Alarrayed S et al (2011) Why does kidney allograft fail? A long-term single-center experience. Saudi J Kidney Dis Transpl. 22:818–824PubMed
15.
go back to reference Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ (2000) Improved graft survival and renal transplantation in the United States, 1988 to 1996. N Engl J Med 342:605–612CrossRefPubMed Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ (2000) Improved graft survival and renal transplantation in the United States, 1988 to 1996. N Engl J Med 342:605–612CrossRefPubMed
16.
go back to reference El-Zoghby ZM et al (2009) Identifying specific causes of kidney allograft loss. Am J Transplant 9:527–535CrossRefPubMed El-Zoghby ZM et al (2009) Identifying specific causes of kidney allograft loss. Am J Transplant 9:527–535CrossRefPubMed
17.
go back to reference Cosio FG, Gloor JM, Sethi S, Stegall MD (2008) Transplant glomerulopathy. Am J Transplant 8:492–496CrossRefPubMed Cosio FG, Gloor JM, Sethi S, Stegall MD (2008) Transplant glomerulopathy. Am J Transplant 8:492–496CrossRefPubMed
18.
go back to reference Naesens M, Kuypers DR, De Vusser K, Evenepoel P, Claes K, Bammens B, Meijers B, Sprangers B, Pirenne J, Monbaliu D, Jochmans I, Lerut E (2014) The histology of kidney transplant failure: a long-term follow-up study. Transplantation 98(4):427–435CrossRefPubMed Naesens M, Kuypers DR, De Vusser K, Evenepoel P, Claes K, Bammens B, Meijers B, Sprangers B, Pirenne J, Monbaliu D, Jochmans I, Lerut E (2014) The histology of kidney transplant failure: a long-term follow-up study. Transplantation 98(4):427–435CrossRefPubMed
19.
go back to reference Gago M, Cornell LD, Kremers WK, Stegall MD, Cosio FG (2012) Kidney allograft inflammation and fibrosis, causes and consequences. Am J Transplant 12:1199–1207CrossRefPubMed Gago M, Cornell LD, Kremers WK, Stegall MD, Cosio FG (2012) Kidney allograft inflammation and fibrosis, causes and consequences. Am J Transplant 12:1199–1207CrossRefPubMed
20.
go back to reference Nankivell BJ et al (2001) Effect of histological damage on long-term kidney transplant outcome. Transplantation 71:515–523CrossRefPubMed Nankivell BJ et al (2001) Effect of histological damage on long-term kidney transplant outcome. Transplantation 71:515–523CrossRefPubMed
21.
go back to reference Serón D (2009) Interstitial fibrosis and tubular atrophy in renal allograft protocol biopsies as a surrogate of graft survival. Transpl Proc 41:769–770CrossRef Serón D (2009) Interstitial fibrosis and tubular atrophy in renal allograft protocol biopsies as a surrogate of graft survival. Transpl Proc 41:769–770CrossRef
22.
go back to reference Roufosse C, Simmonds N, Clahsen-van Groningen M, Haas M, Henriksen KJ, Horsfield C, Loupy A, Mengel M, Perkowska-Ptasińska A, Rabant M, Racusen LC, Solez K, Becker JU (2018) A 2018 reference guide to the banff classification of renal allograft pathology. Transplantation 102:1795–1814CrossRefPubMed Roufosse C, Simmonds N, Clahsen-van Groningen M, Haas M, Henriksen KJ, Horsfield C, Loupy A, Mengel M, Perkowska-Ptasińska A, Rabant M, Racusen LC, Solez K, Becker JU (2018) A 2018 reference guide to the banff classification of renal allograft pathology. Transplantation 102:1795–1814CrossRefPubMed
23.
go back to reference Doorenbos CRC, van den Born J, Navis G, de Borst MH (2009) Possible renoprotection by vitamin D in chronic renal disease: beyond mineral metabolism. Nat Rev Nephrol 5:691–700CrossRefPubMed Doorenbos CRC, van den Born J, Navis G, de Borst MH (2009) Possible renoprotection by vitamin D in chronic renal disease: beyond mineral metabolism. Nat Rev Nephrol 5:691–700CrossRefPubMed
26.
go back to reference Barros X, Rodríguez NY, Fuster D, Rodas L, Esforzado N, Mazza A, Rubello D, Campos F, Tapias A, Torregrosa JV (2016) Comparison of two different vitamin D supplementation regimens with oral calcifediol in kidney transplant patients. J Nephrol 29:703–709CrossRefPubMed Barros X, Rodríguez NY, Fuster D, Rodas L, Esforzado N, Mazza A, Rubello D, Campos F, Tapias A, Torregrosa JV (2016) Comparison of two different vitamin D supplementation regimens with oral calcifediol in kidney transplant patients. J Nephrol 29:703–709CrossRefPubMed
27.
go back to reference Messa P, Regalia A, Alfieri CM (2017) Nutritional vitamin D in renal transplant patients: speculations and reality. Nutrients 9(6):550CrossRefPubMedCentral Messa P, Regalia A, Alfieri CM (2017) Nutritional vitamin D in renal transplant patients: speculations and reality. Nutrients 9(6):550CrossRefPubMedCentral
28.
go back to reference Gago M, Cornell LD, Kremers WK, Stegall MD, Cosio FG (2012) Kidney allograft inflammation and fibrosis, causes and consequences. Am J Transplant 12:1199–1207CrossRefPubMed Gago M, Cornell LD, Kremers WK, Stegall MD, Cosio FG (2012) Kidney allograft inflammation and fibrosis, causes and consequences. Am J Transplant 12:1199–1207CrossRefPubMed
29.
go back to reference Wei Y, Shao R (2006) Transduction of a mesenchyme-specific gene periostin into 293T cells induces cell invasive activity through epithelial-mesenchymal transformation. J Biol Chem 281(28):19700–19708CrossRef Wei Y, Shao R (2006) Transduction of a mesenchyme-specific gene periostin into 293T cells induces cell invasive activity through epithelial-mesenchymal transformation. J Biol Chem 281(28):19700–19708CrossRef
30.
31.
go back to reference Oka T et al (2007) Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling. Circ Res 101:313–321CrossRefPubMedPubMedCentral Oka T et al (2007) Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling. Circ Res 101:313–321CrossRefPubMedPubMedCentral
32.
33.
go back to reference Satirapoj B et al (2014) Urine periostin as a biomarker of renal injury in chronic allograft nephropathy. Transplant Proc 46:135–140CrossRefPubMed Satirapoj B et al (2014) Urine periostin as a biomarker of renal injury in chronic allograft nephropathy. Transplant Proc 46:135–140CrossRefPubMed
34.
35.
go back to reference Masuoka M et al (2012) Periostin promotes chronic allergic inflammation in response to Th2 cytokines. J Clin Investig 122:2590–2600CrossRefPubMed Masuoka M et al (2012) Periostin promotes chronic allergic inflammation in response to Th2 cytokines. J Clin Investig 122:2590–2600CrossRefPubMed
36.
Metadata
Title
Novel markers of graft outcome in a cohort of kidney transplanted patients: a cohort observational study
Authors
C. Alfieri
A. Regalia
G. Moroni
D. Cresseri
F. Zanoni
M. Ikehata
P. Simonini
M. P. Rastaldi
G. Tripepi
C. Zoccali
C. Chatziantoniou
Piergiorgio Messa
Publication date
01-02-2019
Publisher
Springer International Publishing
Published in
Journal of Nephrology / Issue 1/2019
Print ISSN: 1121-8428
Electronic ISSN: 1724-6059
DOI
https://doi.org/10.1007/s40620-018-00580-0

Other articles of this Issue 1/2019

Journal of Nephrology 1/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.